Data from the National Cancer Database, which is heavily dependent on institutional reporting, could be misleading about the burden of sarcomas in the United States. READ MORE
Researchers compared a combination regimen with the current standard of care for first-line treatment of advanced soft-tissue sarcoma.
Differences in the immunologic profiles of soft tissue sarcoma subtypes could have implications for treatment with immune checkpoint inhibitors.
The American Society of Clinical Oncology released new recommendations for managing patients with clinically localized small renal masses.
Childhood survivors of bone cancer and soft-tissue sarcoma face increased risk of hospitalization for years after initial diagnosis.